OneCell Diagnostics has secured $16 million in a Series A round as it aims to limit cancer recurrence using AI advancements along with scientific ways.
© 2024 TechCrunch. All rights reserved. For personal use only.
Posted from: this blog via Microsoft Power Automate.
0 comments:
Post a Comment